scholarly journals Bacteria associated with tunicate, Polycarpa aurata, from Lease Sea, Maluku, Indonesia exhibiting anti-multidrug resistant bacteria

2019 ◽  
Vol 20 (4) ◽  
pp. 956-964 ◽  
Author(s):  
DIAH AYUNINGRUM ◽  
RHESI KRISTIANA ◽  
AYUNDA AINUN NISA ◽  
SEPTHY KUSUMA RADJASA ◽  
SAKTI IMAM MUCHLISSIN ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Ethyl Acetate ◽  
Biological Activities ◽  
Multidrug Resistant ◽  
Coi Gene ◽  
Resistant Bacteria ◽  
Multidrug Resistant Bacteria ◽  
Associated Bacteria ◽  
Preliminary Screening ◽  
Rdna Sequencing

Abstract. Ayuningrum D, Kristiana R, Nisa AA, Radjasa SK, Muchlissin SI, Radjasa OK, Sabdono A, Trianto A. 2019. Bacteria associated with tunicate, Polycarpa aurata, from Lease Sea, Maluku, Indonesia exhibiting anti-multidrug resistant bacteria. Biodiversitas 20: 956-964. Tunicate is a rich secondary metabolites producer with various biological activities whether as an original producer or produced by the associated microorganisms. In this study, a total of 11 tunicate specimens were identified as Polycarpa aurata with four color variations based on morphological characteristic and COI gene identification and BLAST analysis. The P. aurata associated-bacteria were isolated and tested for antimicrobial activity against multi-drug resistant (MDR) bacteria. A total of 86 axenic isolates were successfully purified. Furthermore, nine isolates (10.5%) exhibited antibacterial activity on preliminary screening. Nine prospective isolates were fermented in respective medium (Zobell 2216, modified M1 or modified ISP2 media) then extracted using ethyl acetate. The ethyl acetate extracts from liquid fermentation were tested against MDR Escherichia coli, MDR Bacillus cereus, Methicillin-Resistant Staphylococcus aureus (MRSA) and Methicillin-Sensitive and Staphylococcus aureus (MSSA). As a result, seven isolates (8.1%) still retained the activity at the extract concentration 150 µg/disk. Molecular analysis based on 16S rDNA sequencing revealed the most active isolates, TSB 47, TSC 10 and TSB 34 identified as Bacillus tropicus, Vibrio alginolyticus and Virgibacillus massiliensis, with BLAST homology 99%.

scholarly journals High Colonization Rate and Heterogeneity of ESBL- and Carbapenemase-Producing Enterobacteriaceae Isolated from Gull Feces in Lisbon, Portugal

2020 ◽  
Vol 8 (10) ◽  
pp. 1487
Author(s):  
Marta Aires-de-Sousa ◽  
Claudine Fournier ◽  
Elizeth Lopes ◽  
Hermínia de Lencastre ◽  
Patrice Nordmann ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Staphylococcus Aureus ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
Bacterial Species ◽  
Multidrug Resistant ◽  
Resistant Bacteria ◽  
Multidrug Resistant Bacteria ◽  
Vancomycin Resistant Enterococci ◽  
Vancomycin Resistant ◽  
Encoding Genes

In order to evaluate whether seagulls living on the Lisbon coastline, Portugal, might be colonized and consequently represent potential spreaders of multidrug-resistant bacteria, a total of 88 gull fecal samples were screened for detection of extended-spectrum β-lactamase (ESBL)- or carbapenemase-producing Enterobacteriaceae for methicillin-resistant Staphylococcus aureus (MRSA) and for vancomycin-resistant Enterococci (VRE). A large proportion of samples yielded carbapenemase- or ESBL-producing Enterobacteriaceae (16% and 55%, respectively), while only two MRSA and two VRE were detected. Mating-out assays followed by PCR and whole-plasmid sequencing allowed to identify carbapenemase and ESBL encoding genes. Among 24 carbapenemase-producing isolates, there were mainly Klebsiella pneumoniae (50%) and Escherichia coli (33%). OXA-181 was the most common carbapenemase identified (54%), followed by OXA-48 (25%) and KPC-2 (17%). Ten different ESBLs were found among 62 ESBL-producing isolates, mainly being CTX-M-type enzymes (87%). Co-occurrence in single samples of multiple ESBL- and carbapenemase producers belonging to different bacterial species was observed in some cases. Seagulls constitute an important source for spreading multidrug-resistant bacteria in the environment and their gut microbiota a formidable microenvironment for transfer of resistance genes within bacterial species.

scholarly journals Investigation of the environmental presence of multidrug-resistant bacteria at small animal hospitals in Hungary

2021 ◽  
Author(s):  
Ádám Kerek ◽  
Ágnes Sterczer ◽  
Zoltán Somogyi ◽  
Dóra Kovács ◽  
Ákos Jerzsele
Keyword(s):  
Staphylococcus Aureus ◽  
Susceptibility Testing ◽  
Small Animal ◽  
Multidrug Resistant ◽  
Resistant Bacteria ◽  
Multidrug Resistant Bacteria ◽  
Antibiotic Resistant ◽  
Hygiene Measures ◽  
High Prevalence ◽  
Vancomycin Resistant

AbstractMultidrug-resistant bacteria can cause severe nosocomial infections in both human and veterinary clinics. The aim of this study was to investigate the presence and antibiotic susceptibility of Enterococcus, Staphylococcus and Pseudomonas strains at four small animal clinics of Hungary in 2018, as these bacteria can reliably represent the level of antimicrobial resistance in the investigated environment. A total of 177 Staphylococcus colonies were found, including 22 Staphylococcus pseudintermedius and 13 Staphylococcus aureus. As regards enterococci, 9 Enterococcus faecium, 2 E. faecalis and further 286 Enterococcus strains were isolated. The number of Pseudomonas aeruginosa isolates (n = 34) was considered too low for relevant susceptibility testing. Among staphylococci, the highest resistance was found to sulphamethoxazole (82.9%), penicillin (65.7%) and erythromycin (54.3%), while in the case of enterococci, resistance to norfloxacin and rifampicin was the most common, with 25.5% of the strains being resistant to both antibiotics. Ten methicillin-resistant S. pseudintermedius (MRSP) and six vancomycin-resistant Enterococcus (VRE) strains could be identified. Only 5.7% of the Staphylococcus isolates were susceptible to all tested agents, while this ratio was 36.2% among enterococci. The results of this study have revealed a high prevalence of antibiotic-resistant bacteria in Hungarian small animal clinics, which highlights the importance of regular disinfection processes and stringent hygiene measures in veterinary clinics.

scholarly journals Occurrence of Antibiotic Resistant Bacteria in Environmental Wastes

Our Nature ◽  
1970 ◽  
Vol 7 (1) ◽  
pp. 151-157
Author(s):  
R.C. Poudel ◽  
D.R. Joshi ◽  
N.R. Dhakal ◽  
A.B. Karki
Keyword(s):  
Staphylococcus Aureus ◽  
Sewage Sludge ◽  
Antibiotic Susceptibility ◽  
Multidrug Resistant ◽  
Resistant Bacteria ◽  
Multidrug Resistant Bacteria ◽  
Antibiotic Resistant ◽  
Antibiotic Susceptibility Pattern ◽  
Antibiotic Susceptibility Test ◽  
Enterococcus Spp

Microbial resistance to antibiotics has been emerging in environmental isolates. This study was carried out from October 2008 to January 2009 to describe the antibiotic susceptibility pattern of the bacteria isolated from sewage sludge, biowaste and bioslurry samples. A total of 49 identified isolates were taken for antibiotic susceptibility test. Amikacin and Gentamicin were the effective antibiotics for the Gram negative bacteria, comparatively Escherichia coli was the most sensitive. Similarly, all isolates of Staphylococcus aureus and Enterococcus spp. were sensitive to Tetracycline and Erythromycin respectively and none of these isolates were resistant to Vancomycin. Out of 13 S. aureus, five (38.5%) were Methicillin resistant Staphylococcus aureus (MRSA). The multidrug resistant (MDR) isolates accounted for 46.9%, the highest percentage of MDR isolates was seen in Pseudomonas aeruginosa (9/12, 75.0%). The proper management of multidrug resistant bacteria present in waste is suggestive for environmental and public health.Key words: Multidrug resistant bacteria, Bio-waste, Sewage sludge, BioslurryDOI: 10.3126/on.v7i1.2563Our Nature (2009) 7:151-157 

scholarly journals Synthesis of photo-excited Chlorin e6 conjugated silica nanoparticles for enhanced anti-bacterial efficiency to overcome methicillin-resistant Staphylococcus aureus

2019 ◽  
Vol 55 (18) ◽  
pp. 2656-2659 ◽  
Author(s):  
Jia-fu Lin ◽  
Juan Li ◽  
Ashna Gopal ◽  
Tasnim Munshi ◽  
Yi-wen Chu ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Photodynamic Therapy ◽  
Silica Nanoparticles ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
Multidrug Resistant ◽  
Chlorin E6 ◽  
Resistant Bacteria ◽  
Multidrug Resistant Bacteria ◽  
Methicillin Resistant

Nano photodynamic therapy to overcome multidrug resistant bacteria.

scholarly journals Cold Atmospheric-Pressure Plasma Caused Protein Damage in Methicillin-Resistant Staphylococcus aureus Cells in Biofilms

2021 ◽  
Vol 9 (5) ◽  
pp. 1072
Author(s):  
Li Guo ◽  
Lu Yang ◽  
Yu Qi ◽  
Gulimire Niyazi ◽  
Lingling Huang ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Atmospheric Pressure ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
Atmospheric Pressure Plasma ◽  
Multidrug Resistant ◽  
Resistant Bacteria ◽  
Multidrug Resistant Bacteria ◽  
Methicillin Resistant ◽  
Pressure Plasma ◽  
Cold Atmospheric Pressure Plasma

Biofilms formed by multidrug-resistant bacteria are a major cause of hospital-acquired infections. Cold atmospheric-pressure plasma (CAP) is attractive for sterilization, especially to disrupt biofilms formed by multidrug-resistant bacteria. However, the underlying molecular mechanism is not clear. In this study, CAP effectively reduced the living cells in the biofilms formed by methicillin-resistant Staphylococcus aureus, and 6 min treatment with CAP reduced the S. aureus cells in biofilms by 3.5 log10. The treatment with CAP caused the polymerization of SaFtsZ and SaClpP proteins in the S. aureus cells of the biofilms. In vitro analysis demonstrated that recombinant SaFtsZ lost its self-assembly capability, and recombinant SaClpP lost its peptidase activity after 2 min of treatment with CAP. Mass spectrometry showed oxidative modifications of a cluster of peaks differing by 16 Da, 31 Da, 32 Da, 47 Da, 48 Da, 62 Da, and 78 Da, induced by reactive species of CAP. It is speculated that the oxidative damage to proteins in S. aureus cells was induced by CAP, which contributed to the reduction of biofilms. This study elucidates the biological effect of CAP on the proteins in bacterial cells of biofilms and provides a basis for the application of CAP in the disinfection of biofilms.

Survival capability of healthcare-associated, multidrug-resistant bacteria on untreated and on antimicrobial textiles

2018 ◽  
Vol 48 (7) ◽  
pp. 1113-1135 ◽  
Author(s):  
Adrienn Hanczvikkel ◽  
András Víg ◽  
Ákos Tóth
Keyword(s):  
Escherichia Coli ◽  
Staphylococcus Aureus ◽  
Multidrug Resistant ◽  
Resistant Bacteria ◽  
Cotton Textile ◽  
Multidrug Resistant Bacteria ◽  
Gram Negative ◽  
Untreated Cotton ◽  
Antimicrobial Efficiency ◽  
Healthcare Associated

Healthcare-associated infections are of global concern, and textiles can contribute to the transmission of pathogens. In this study, we examined quantitatively the survival capability of 60 multidrug-resistant bacterial strains from four species ( Klebsiella pneumoniae, Acinetobacter baumannii, Staphylococcus aureus and Enterococcus faecium) on untreated cotton textile in clinically relevant incubation periods. We determined the antibacterial efficiency of textiles treated either with quaternary ammonium compound (QAC)-containing Sanitized T99-19 liquid (50 m/m% Dimethyltetradecyl (3-(trimethoxysilyl)propyl) ammonium-chloride) or with silver salt-containing Sanitized T27-22 Silver liquid (2 m/m% AgCl and 8 m/m% TiO2) as well. Finally, we compared the results of the healthcare-associated, multidrug-resistant strains and antibiotic-sensitive, quality control standard strains (ATCC 25922, ATCC 11105 Escherichia coli, and ATCC 25923, ATCC 6538 Staphylococcus aureus) often used in antimicrobial efficiency tests. The results revealed that all investigated multidrug-resistant bacteria are able to survive on untreated cotton textile and pose health risk in hospitals. During one day the T27-22-Silver-treated textile was able to eliminate most of the Gram-positive pathogens, reducing the risk of cross-contamination, but none of the examined agents destroyed the multidrug-resistant, Gram-negative isolates. The antibiotic-susceptible and the multidrug-resistant Staphylococcus aureus strains had similar survival capability and biocide-tolerance, while the risk of infections caused by multidrug-resistant, Gram-negative pathogens could be extremely underestimated using only ATCC Escherichia coli standard strains. Our results also draw attention to the careful evaluation of antimicrobial efficiency tests and indicate that a significant reduction of bacterial count does not necessarily mean significant antibacterial efficiency that would be suitable to avoid infections.

scholarly journals Efficacy of commercial bacteriophage products against ESKAPE pathogens

2020 ◽  
pp. 18-24
Author(s):  
NS Kuptsov ◽  
MA Kornienko ◽  
RB Gorodnichev ◽  
DI Danilov ◽  
MV Malakhova ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Pseudomonas Aeruginosa ◽  
Klebsiella Pneumoniae ◽  
Enterococcus Faecium ◽  
Enterobacter Cloacae ◽  
Multidrug Resistant ◽  
Resistant Bacteria ◽  
Multidrug Resistant Bacteria ◽  
Spot Tests ◽  
Eskape Pathogens

The ever-rising prevalence of multidrug-resistant bacteria necessitates the search for a therapeutic alternative to antibiotics. Using therapeutic products based on virulent bacteriophages might provide such an alternative. The aim of our study was to evaluate the efficacy of commercial phage products and natural bacteriophage monoisolates recovered from environmental sources against clinical strains of Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa. We compiled a collection of 147 strains that were subsequently genotypes using the MLST method. The efficacy of bacteriophages was evaluated in spot tests. The highest efficacy was demonstrated by "Staphylococcal bacteriophage" (86%, effective against S. aureus), "Purified polyvalent pyobacteriophage" (87.8%, effective against K. pneumoniae), and a group of phage products against P. aeruginosa, including "Pseudomonas aeruginosa bacteriophage" (87.5%), "Complex pyobacteriophage" (79.5–90%) and "Purified polyvalent pyobacteriophage" (90–92.5%). The efficacy of "Intesti bacteriophage", which targets E. faecium, was 4.2%. The efficacy of commercial phage products against S. aureus and K. pneumoniae was higher than the efficacy of individual phage monoisolates (60% for the S. aureus phage vB_SauP-436-3w and 5.9% for the K. pneumoniae phage vB_Kp_M_ Seu621). Thus, all tested commercial phage products were highly effective against P. aeruginosa, K. pneumoniae and S. aureus. There are no commercial phage products on the market against other ESKAPE pathogens, including Acinetobacter baumannii and Enterobacter cloacae. Besides, there are no effective phage products against E. faecium. This dictates the need for new effective bacteriophages against these species.

Sign in / Sign up

Export Citation Format

Share Document